Hochschulschrift
FAT1 expression and function in chronic liver disease and hepatocellular carcinoma
- Alternative title
-
FAT1 Expression und Funktion in chronischen Lebererkrankungen und im hepatozellulären Karzinom
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Regensburg, Universität Regensburg, Diss., 2013
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Regensburg
- (who)
-
Universitätsbibliothek Regensburg
- (when)
-
2013
- Creator
- Contributor
-
Hellerbrand, Claus
- URN
-
urn:nbn:de:bvb:355-epub-282029
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-03-25T13:49:25+0100
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Valletta, Daniela
- Hellerbrand, Claus
- Universitätsbibliothek Regensburg
Time of origin
- 2013
Other Objects (12)
Fat1 expression and function in chronic liver disease and hepatocellular carcinoma
Chronic liver diseases and hepatocellular carcinoma : update in 2013 ; 35 tables
Chronic hepatitis B and hepatocellular carcinoma: novel therapeutic concepts
Hepatocellular carcinoma and liver metastases : diagnosis and treatment ; with 21 tables
Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
Epidemiology and risk factors for primary liver cancer : hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Role and regulation of the metalloproteinase ADAM8 in liver inflammation and hepatocellular carcinoma
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
Immunotherapeutic Approaches for the Treatment of Chronic HBV Infection and Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis
Fat1 expression and function in chronic liver disease and hepatocellular carcinoma
Chronic liver diseases and hepatocellular carcinoma : update in 2013 ; 35 tables
Chronic hepatitis B and hepatocellular carcinoma: novel therapeutic concepts
Hepatocellular carcinoma and liver metastases : diagnosis and treatment ; with 21 tables
Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
Epidemiology and risk factors for primary liver cancer : hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Role and regulation of the metalloproteinase ADAM8 in liver inflammation and hepatocellular carcinoma
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
Immunotherapeutic Approaches for the Treatment of Chronic HBV Infection and Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis
Fat1 expression and function in chronic liver disease and hepatocellular carcinoma
Chronic liver diseases and hepatocellular carcinoma : update in 2013 ; 35 tables
Chronic hepatitis B and hepatocellular carcinoma: novel therapeutic concepts
Hepatocellular carcinoma and liver metastases : diagnosis and treatment ; with 21 tables
Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
Epidemiology and risk factors for primary liver cancer : hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Role and regulation of the metalloproteinase ADAM8 in liver inflammation and hepatocellular carcinoma
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
Immunotherapeutic Approaches for the Treatment of Chronic HBV Infection and Hepatocellular Carcinoma
Subclinical hepatocellular carcinoma
Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease